Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes

• Published in: Cancer research (Chicago, Ill.) Vol. 64; no. 11; pp. 3757 - 3760
• Main Authors: SHIVAPURKAR, Narayan, TAKAHASHI, Takao, KROFT, Steven H, TIMMONS, Charles, MCKENNA, Robert W, ZIDING FENG, GAZDAR, Adi F, REDDY, Jyotsna, YINGYE ZHENG, STASTNY, Victor, COLLINS, Robert, TOYOOKA, Shinichi, SUZUKI, Makato, PARIKH, Gunjan, ASPLUND, Sheryl
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Association for Cancer Research 01-06-2004
• Subjects: Antineoplastic agents; Biological and medical sciences; DNA Methylation; DNA, Viral - genetics; Epstein-Barr virus; Herpesvirus 4, Human - genetics; Humans; Leukemia - blood; Leukemia - genetics; Leukemia - virology; Leukocytes, Mononuclear - virology; Lymphoma, Non-Hodgkin - blood; Lymphoma, Non-Hodgkin - genetics; Lymphoma, Non-Hodgkin - virology; Medical sciences; Pharmacology. Drug treatments; Promoter Regions, Genetic; Simian virus 40; Simian virus 40 - genetics; Tumors; Virus; Human; Gene; Nucleotide sequence; Transcription promoter; Lymphoproliferative syndrome; Polyomavirus; Genetics; Malignant hemopathy; Papovaviridae; Methylation; Simian virus 40
• DOI: 10.1158/0008-5472.can-03-3307
• EISSN: 1538-7445
• ISSN: 0008-5472

The simian polyoma virus SV40 has been detected in specific human tumors including non-Hodgkin's lymphomas, although a causative role for the virus has not been convincingly demonstrated. Aberrant methylation of CpG islands in promoter regions is a frequent method of silencing tumor suppressor genes (TSGs) in cancers and may be induced by oncogenic viruses. We investigated the relationship between the presence of SV40 or EBV DNA sequences and the methylation profiles for 10 TSGs in 90 cases of non-Hodgkin's lymphomas/leukemias and 56 control tissues. SV40 sequences were present in 33/90 (37%) non-Hodgkin's lymphomas/leukemias, and EBV was present in 11/42 (26%) of non-Hodgkin's lymphomas. We found a highly significant correlation between the presence of SV40 and methylation of seven genes (P values, 0.006 to <0.0001). In lymphomas, there was no relationship between EBV and methylation. Oncogenic viruses and methylation were rarely present in control tissues. We investigated methylation of the same 10 TSGs in peripheral blood mononuclear cells (PBMC) from a healthy volunteer infected with EBV or EBV and SV40. Promoter methylation of CDH1 and CDH13 were noted in dual SV40- and EBV-infected PBMC, and these two genes were also highly significantly correlated to the presence of SV40 sequences in tumors. SV40 infection also resulted in appearance of the lymphoma/leukemia-specific marker, methylated SHP1. Methylation was completely absent in uninfected and EBV-infected PBMC. Our results demonstrate that the presence of SV40 in hematological malignancies is associated with promoter methylation of TSGs and that in all probability, the virus plays a role in tumor pathogenesis.